Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(20%)
Results Posted
50%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
9
90%
Ph early_phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Active, not recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
85.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

withdrawn110%
active_not_recruiting220%
completed660%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10